GENB Generate Biomedicines, Inc.
P/E
--
Forward P/E
--
Price/Sales
64.02
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 Generate Biomedicines is trading 7.7% up today after positive Moderna personalized cancer-vaccine trial results
Generate Biomedicines is trading 7.7% up now at $17.32 after biotechnology shares rallied broadly on positive Moderna personalized cancer-vaccine trial...
🟢 Generate Biomedicines is trading 4.62% up today; immediate cause unclear
Generate Biomedicines is trading at $16.41 (+4.62%), with the immediate cause unclear. - No clear company-specific announcement or filing dated August 18,...